Trials / Unknown
UnknownNCT05842993
Study of Hydrogen Inhalation Compared With Placebo in Type 2 Diabetes Patients
Efficacy and Safety of Hydrogen Inhalation in Subjects With Type 2 Diabetes
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 96 (estimated)
- Sponsor
- Qingdao University · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the efficacy and safety of hydrogen inhalation in type 2 diabetes patients.
Detailed description
The objective of the study is to evaluate the efficacy and safety of hydrogen inhalation compared with placebo in patients with type 2 diabetes mellitus after 12-week treatment in a randomized, double-blind, placebo-controlled design.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Hydrogen generator | Patient inhales hydrogen gas for 2 hours per day in the flow rate of 2L/min via nasal cannula by applying hydrogen generator (HZS-2700A, Qingdao Haizhisheng Corp.,LTD, Qingdao, China) for 12 weeks. |
| DEVICE | Analogue machine | Patient inhales normal air for 2 hours per day in the flow rate of 2L/min via nasal cannula with analogue machine for 12 weeks. This machine has the same appearance as the hydrogen generator. |
Timeline
- Start date
- 2023-05-01
- Primary completion
- 2023-10-10
- Completion
- 2023-10-10
- First posted
- 2023-05-06
- Last updated
- 2023-05-31
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05842993. Inclusion in this directory is not an endorsement.